Hyderabad is fast emerging as destination for pharma and bio-tech industries with projected growth of 30 to 40 per cent, consultant company Frost and Sullivan has said.
"Andhra Pradesh government is showing its interest in developing this industries and they have declared so many facilities to woo them in their state," Aroop Zutshi, president of Frost and Sullivan, told reporters in Panaji on the sidelines of a two-day global summit on Opportunities in life sciences molecules, which began on Monday.
"Nearly 50 per cent of this industry is based in Bangalore, 25 per cent in Hyderabad and rest in other parts of the country," he said.
Of the $75 billion life science industry, India attributes for just $2.5 billion with estimated 10 per cent growth, he said.
Do you want to discuss stock tips? Do you know a hot one? Join the Stock Market Investments Discussion Group